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Weight control by exercise and dietary 
calorie restriction (DCR) has been associated with 
reduced cancer risk, but the underlying 
mechanisms are not well understood. This study 
was designed to compare the effects of weight loss 
by increasing physical activity or decreasing 
calorie intake on tumor promoter-induced Ras-
MAPK and PI3K-Akt pathways. SENCAR mice 
were randomly assigned to one of the following 
five groups: ad libitum-fed sedentary control, ad 
libitum-fed exercise (AL+Exe), exercise but pair-
fed at the amount as controls (PF+Exe), 20% 
DCR, and 20% DCR plus exercise (DCR+Exe). 
After 10-wks, body weight and body fat 
significantly decreased in the groups of DCR, 
DCR+Exe, and PF+Exe when compared with the 
controls. AL+Exe did not induce weight loss due 
to, at least in part, increased food intake. Plasma 
IGF-1 levels reduced significantly in DCR and 
DCR+Exe but not PF+Exe. The protein H-Ras and 
activated Ras-GTP significantly decreased in 
TPA-induced skin tissues of DCR-fed mice but 
not exercised mice. PI3K protein, phosphor-serine 
Akt, and p42/p44-MAPK were reduced, however, 
in both DCR and PF+Exe groups. 
Immunohistochemistry demonstrated that the 
significantly reduced H-Ras occurred in 
subcutaneous fat cells, while the reduced PI3K and 
PCNA took place only in epidermis. Plasma leptin 
decreased in PF+Exe, DCR, and DCR+Exe, while 
the caspase-3 activity increased in DCR+Exe only. 
Genomic microarray analysis further indicated that 
the expression of 34 genes relevant to PI3K and 31 
genes to MAPK pathway were significantly 
regulated by either DCR or PF+Exe treatments. 
The reduced PI3K in PF+Exe mice was partially 
reversed by IGF-1 treatment. The overall results of 
this study demonstrated that DCR abrogated both 
Ras and PI3K signaling, which might inhibit TPA-
induced proliferation and anti-apoptosis. Selective 
inhibition if PI3K by PF+Exe but not AL+Exe 
seems more attributable to the magnitude of the 
caloric deficit and/or body fat loss than diet vs. 
exercise comparison. 
 
The National Health and Nutrition 
Examination Survey have indicated growing rates 
of obesity in American adults and overweight 
children over the past 20 years (1). Numerous 
prospective and case-control studies associated 
with weight control and physical activity estimate 
that excess body weight and sedentary life style 
account for about 39% of endometrial, 25% of 
kidney, 11% of colon, 9% of postmenopausal 
breast cancer, and 5% of total cancer incidence (2-
3).  It has been suggested that those 25% over 
normal weight have a 33% greater cancer risk than 
those who maintain ideal body weight (4). 
Therefore, for many individuals, it would be 
advisable to maintain weight within normal range 
to reduce their risk of cancer.   
Overweight/obesity is recognized as a 
reflection of a positive energy state that results 
from either over-consumption of energy or low 
energy expenditure. There is ample evidence that 
weight control via decreasing calorie intake and/or 
increasing physical activity reduces cancer risk in 
animal models. For almost a century, dietary 
calorie restriction (DCR1) has been shown to 
inhibit the development of spontaneous, 
transplanted, chemically, and virally induced 
cancer in animal models (5-6). Many types of 
cancers, including mammary, liver, colon, skin, 
pancreas, bladder, and leukemia, have been shown 
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to be prevented by 20-40% DCR (7-8). 
Alternatively, exercise, an effective method for 
energy expenditure, has been also shown to reduce 
both the incidence of DMBA-induced colon 
tumors and the growth of transplanted tumors in 
rats (4, 9-10). Voluntary wheel running has been 
reported to inhibit UVB-induced skin 
carcinogenesis in hairless SKH-1 mice (11). The 
inhibition of tumor development by exercise is, 
however, modest if not combined with dietary 
restriction (12).  
There are several hypotheses proposed to 
describe mechanisms by which weight control 
may reduce tumor development, including 
decreased oncogene expression, assisted DNA 
repair, scavenged reactive oxygen species, and 
altered levels of cancer-related hormones. 
Hormone alteration seems to be a critical factor for 
cancer prevention by weight control due to the 
significant role of hormones in regulating cellular 
growth. Previous researchers have found that the 
levels of insulin (13), IGF-1 (14-16) and leptin 
(14-17) decreased significantly in DCR-fed mice. 
As a mitogen, IGF-1 is known to stimulate 
cell proliferation, inhibit apoptosis, and enhance 
angiogenesis (18). Chronically high levels of IGF-
1 have been linked with an increased risk of 
developing breast (19-20), colon (21-22), and 
prostate (23) cancers in several case-control and 
prospective cohort studies. It has been suggested 
that the role of IGF-1 in mitogenesis is triggered 
through cellular signaling cascades leading to the 
activation of both mitogen activated protein kinase 
(MAPK) and phosphatidylinositol 3-kinase (PI3K) 
pathways (24). 
The 12-0-tetradecanoylphorbol-13-acetate 
(TPA) is a cancer promoter that is topically 
applied to experimental mice in the skin cancer 
model (25-26). TPA can induce ras gene 
expression via Ras Guanyl Nucleotide- Releasing 
Protein (RasGRP). RasGRP is a family of guanyl 
nucleotide exchange factors and has been reported 
to be expressed in mouse epidermal keratinocytes 
in response to phorbol ester treatment (27-28).  
The activation of RasGRP by TPA is usually 
accompanied by subsequent Ras-mediated down-
stream regulation, especially of the MAPK 
pathway (28). 
Ras, a G-protein effector of IGF-1, is an 
important upstream regulator of the MAPK and 
PI3K pathways (29-30). Three ras genes have been 
identified in the mammalian genome: H-ras, K-ras 
and N-ras. They have similar structure and 
sequences and each codifies a monometric G 
protein of 21 KDa (29-30). H-ras is highly 
expressed in the skin and skeletal muscles, K-ras 
is mostly expressed in the colon and thymus, and 
N-ras is expressed in male germinal tissue and 
thymus (30). H-Ras and K-Ras are reported to be 
more responsive to the Raf-1/MAPK pathway. Ras 
becomes activated as a result of extracellular 
signals by the effect of its interaction with guanine 
exchange factors such as SOS. The combination of 
SOS and Ras stimulates GDP release. GTP then 
shifts from SOS to Ras (31). Activated GTP-
bound Ras further initiates the MAPK cascade. 
Previous studies demonstrated that DCR treatment 
inhibited TPA-promoted skin carcinogenesis by 
reducing certain isoforms of PKC (32) down to the 
ERK pathway (33), and then repressing 
transcriptional regulation of AP-1 (34). 
PI3K contains the p85 regulatory subunit 
(which has two SH2 Domains) and a 110 KD 
catalytic subunit (35). The PI3K’s constitute a 
family of eight distinct PI3K isoforms divided into 
three classes according to their sequence 
homology and substrate preference. Class Ia, 
including p110α, p110β, and p110δ, is associated 
with a p85 regulatory subunit to form a 
heterodimeric complex. The p85 subunit has a 
binding site for both insulin and IGF-1 receptors. 
Thus, PI3Kα, β, and δ can be drawn the 
membrane and activated upon the 
autophosphorylation of tyrosine residues of IGF-1 
receptor (36). In addition, Class Ia PI3K also can 
be activated by Ras-GTP via direct interaction 
with the catalytic subunit (37). Class Ib has only 
one member, p110γ, which is triggered by 
activated α, β, and γ heterotrimeric G-protein (37-
38).  PI3K down to Akt may modulate the function 
of numerous substrates involved in the regulation 
of cell survival, cell cycle progression, and cellular 
anti-apoptosis (39).  
This study was designed to compare the 
effects of weight loss by DCR-fed or exercise-
trained mice on Ras-MAPK and PI3K-Akt 
cascades. We provide novel evidence that these 
signaling pathways are potential targets by DCR 
and/or exercise for the inhibition of phorbol ester-
induced skin tumor promotion. This is of 
particular interest because the key role of DCR- or 
exercise-induced weight control for these signal 
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pathways in cancer promotion by which IGF-1 
and/or other hormones such as insulin and leptin 
may be involved is largely unknown. Better 
understanding the relationship between body 
weight status, endocrine hormone changes, and 
hormone-dependent signal pathway activation may 
lead to a novel approach for cancer prevention. 
EXPERIMENTAL PROCEDURES 
Animals and treatments: Female SENCAR mice 
were purchased from NIH (Frederick, MD) at 8 
wks of age (30 ± 2 g). The SENCAR mouse was 
developed by a special breeding of CD-1 with skin 
tumor-sensitive mice for enhanced susceptibility 
to TPA-promoted skin carcinogenesis as originally 
described by Routwell (40). The averaged body 
weight was reduced (27.6 ± 2.8 g) after one-wk 
acclimation to new facility and diet change from 
rodent chow to AIN-93 purified diet. Mice were 
then randomly divided into one of the five groups: 
ad libitum sedentary (Control), ad libitum exercise 
(AL+Exe), Pair-fed plus exercise (PF+Exe), 20% 
DCR (DCR) and 20% DCR plus exercise 
(DCR+Exe). The PF+Exe group was paired-fed at 
the same amount as the control group. The mice 
were fed either a basal diet (AIN-93) or a 20% 
DCR diet for 12 wks. The 20% DCR diet was 
formulated and provided by Harlan Teklad 
(Madison, WI). Briefly, the DCR diet consisted of 
20% less total calories from carbohydrates and fat 
in comparison with the basal AIN-93 diet, while 
the levels of protein and essential micronutrients 
were kept as same as the basal diet. The amount of 
food that each mouse consumed was recorded 
daily and averaged to determine the amount for the 
following week of the DCR and pair-fed 
consumption. A zero-grade adjustable-speed 
rodent treadmill (Boston Gears, Boston, MA) was 
used to exercise the mice. After a two-wk training 
period, mice performed treadmill exercise at 13.4 
m/min for 60 min/d, 5 d/wk for 10 wks. Mice were 
housed individually in an environmentally 
controlled room maintained at 75 ± 1º and 80% 
relative humidity with a 12 h light/12 h dark cycle. 
To take into account the biological clocks of 
nocturnal rodents, the light cycle was adjusted for 
mice to run nighttime exercise. Body weights were 
recorded weekly. In the last two wks, some mice 
in PF+Exe group were received i.p. injection of 
either saline (sham) or IGF-1 (Novozymes 
GroPep, Australia) at 10 μg/g B.W. twice per 
week for IGF-1 treatment. The mice were fed until 
the last day, but exercise was stopped 24 hrs after 
the last bout. In the end of experiment, the dorsal 
skin of the mice was shaved and topically treated 
once with TPA at 3.2 nmol. Mice were sacrificed 
two hours after TPA treatment. The dorsal skin 
samples were snap-frozen in liquid nitrogen and 
kept at -70 ºC until further analyses. 
Body fat analysis: Total body composition and 
bone mineral density were measured with a dual-
energy X-ray absorptiometer scan (DXA) using 
small animal software (v5.6, Prodigy, Lunar-
General Electric, Milwaukee, WI). Mice at the 
final week were anesthetized with sodium 
pentobarbitol prior to scanning. Body fat and bone 
mineral density were recorded from the DXA and 
presented as a percentage of the controls. 
Assessment of plasma IGF-1 and leptin levels: 
Blood samples were obtained directly by 
decapitation and collected in heparin-coated tubes. 
Plasma was isolated by centrifugation at 1,000 g 
for 10 min at 4 ˚C. Total IGF-1 in plasma was 
extracted by Acid-ETOH method and was then 
measured by a RIA kit (Nichols Institute 
Diagnostic, San Clemente, CA). Plasma leptin 
levels were determined using a commercial murine 
leptin RIA kit (Linco Diagnosrics, St. Charles, 
MO). 
Assessment of protein levels by western 
blotting: Western analysis was performed as 
described previously (41). Briefly, mouse skin 
tissues were homogenized in triton lysis buffer. 
Protein concentration was measured in the 
supernatant and 50 μg of whole cell protein was 
electrophoresed on 12% SDS polyacrylamide gel. 
The protein bands were transferred to a 
nitrocellulose membrane, and then the transferred 
bands of H-Ras (21 KDa), K-Ras (21 KDa), PI3K 
(110 KDa) and β-actin (internal control, 43 KDa) 
were respectively bound to their monoclonal 
antibodies purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA). The 
monoclonal antibodies against IGF-1R beta (98 
KDa) was provided by Upstate Inc. (Waltham, 
MA). Antibodies for p42/p44-MAPK (42/44 
KDa), Akt (62 KDa), and p473-Akt (62 KDa) 
were provided by Cell Signaling Technology, Inc. 
(Danvers, MA). The bound proteins were treated 
with the appropriate HRP-conjugated secondary 
antibody (Santa Cruz Biotechnology Inc., Santa 
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Cruz, CA) and visualized by the FluorChemTM 
8800 Advanced Imaging System (Alpha Innotech, 
San Leandro, CA). The expression levels of the 
proteins were qualified by a same imaging system. 
The relative density of the target band was 
normalized to the loading control β-actin and then 
expressed as a percentage of the controls. 
Assessment of Activated Ras-GTP protein 
levels by pull down assay: Total activated Ras 
was determined by a pull down assay kit from 
Upstate Inc. (Waltham, MA). Briefly, the whole 
skin cell lysate was prepared in triton lysis buffer. 
The activated Ras in each 100 μg of cell lysate 
was then pelleted with 10 μL Raf-1 RBD agarose 
beads (Upstate Inc., Waltham, MA) at 12,000 g for 
15 min. The pellet was washed in washing buffer 
three times. Pelleted samples were eluted in 2X 
loading buffer and boiled for 5 min. Samples were 
then loaded onto an 12% SDS-PAGE and 
transferred to a nitrocellulose membrane.  The 
level of target protein was determined by anti-Ras 
IgG2aκ, specifically recognizing p21 H-, K- and N-
Ras, followed by a goat anti-mouse-HRP 
conjugated IgG (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA). The level of the activated GTP 
bound Ras was visualized by the FluorChemTM 
8800 Advanced Imaging System as described 
before. 
Assessment of local protein expression in skin 
tissue cells by immunohistochemistry: The 
flash-frozen dorsal skin tissues of mice were fixed 
in absolute ethanol overnight at -70 ºC, followed 
by 70% ethanol at 4 ºC, 50% ethanol at room 
temperature, and then rinsed with PBS before 
adding 10% formaldehyde. Then the skin tissues 
were set on edge in paraffin blocks to best 
demonstrate full skin thickness. Five micrometer 
sections of each skin sample were cut and 
mounted on positive precharged slides to ensure 
optimal adhesion. The sections were 
deparaffinized and rehydrated through 3 times of 
xylene incubation, twice of absolute ethanol, twice 
of 70% ethanol wash, and one PBS rinse. After 
endogenous peroxidase quenching (0.3% H2O2 in 
PBS for 20 min), antigens were retrieved by 
steaming at 95 ºC for 30 min with a commercial 
antigen retrieval solution (Dakocytomation, 
Carpinteria, CA). Following PBS washes, sections 
were incubated with 1/200 dilution of either one of 
the primary monoclonal antibodies that recognized 
mouse H-Ras (Santa Cruz Biotechnology, Santa 
Cruz, CA), PI3K (Santa Cruz Biotechnology, 
Santa Cruz, CA), PCNA (Invitrogen, Carlsbad, 
CA), caspase-3 (Sigma, St Louis, MO), and leptin 
(Affinity Bioreagents, Golden, CO), respectively. 
The incubation was kept for 2 hrs at room 
temperature in Tris-HCl buffer with 1% goat 
serum. Negative control slides were incubated 
with goat IgG only and without primary 
antibodies. Immunochemistry was performed 
using a biotin-streptavidin peroxidase technique 
(BioGenex, San Ramon, CA). Staining was 
developed with diaminobenzidine chromogen 
(BioGenex, San Ramon, CA). Staining density in 
epidermis, dermis, follicles, and subcutaneous fat 
of each section was blindly graded by the internal 
medicine residents using computer standards 
under guidance of a pathologist without 
knowledge of tissue treatment. The standards of 
staining intensity were respectively established at 
400x by grading up to 40 cells in 5 unit increments 
from 3-5 mice per group. Data were statistically 
calculated and group difference scores with p ≤ 
0.05 were considered significant. 
Caspase-3 activity assay: The activity of caspase-
3 was measured using the fluorogenic substrate 
method (Kamiya Biomedical Company, Seattle, 
WA). Briefly, mouse skin tissue was homogenized 
in HEPES lysis buffer. Cell lysate at 500 μg of 
total protein content was incubated with the 
freshly prepared colorimetric substrate (N-acetyl-
Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl 
coumarin) at 5 µM, 37 ˚C for 30 min. The release 
of 7-amino-4-trifluoromethyl coumarin was then 
measured by a fluorescence spectrophotometer at 
400 nm excitation and 505 nm emission. 
Microarray analysis: Microarray analysis was 
performed by the Microarray Core of the Mental 
Retardation Research Center at the University of 
Kansas Medical Center. Four samples from four 
groups including the control, AL+Exe, PF+Exe, 
and DCR groups were analyzed as follows. Ten μg 
of total RNA was annealed with 100 pmol of 
T7(dT)24 at 70 ºC for 10 min. Then the annealed 
mRNA was reverse transcribed into cDNA using 
the Superscript Choice System kit (Invitrogen 
Corp., Carlsbad, CA). Biotinylated antisense 
cRNA was prepared using the Enzo BioArray 
High Yield RNA Labeling kit (Enzo Diagnostics, 
Farmingdale, NY). After purification of labeled 
cRNA using Rneasy RNA Purification Mini kit 
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(Qiagen), 20 μg biotin labeled cRNA was 
incubated in fragmentation buffer (40 mM Tris-
Acetate, pH 8.1, 100 mM potassium acetate, 30 
mM magnesium acetate) at 94 ºC for 35 min. The 
labeled cDNA then was applied to an Affymetrix 
oligonucleotide array, a GeneChipR Mouse 
Genome 430 2.0 Array (Affymetrix, Santa Clara, 
CA) containing 39,000 transcripts with 45,101 
probe sets. The genechip was hybridized, washed, 
and scanned using Affymetrix equipment and 
protocols (Affymetrix, Santa Clara, CA).  Image 
data were quantified using genechip operating 
software 1.0 (GCOS 1.0). The detection calls of 
probe sets were determined using default settings 
(α1, 0.04; α2, 0.06; δ, 0.015; scale factor, 1.0; 
norm factor, 1.0). If a particular probe set was 
marked as "absent", the probe set was removed 
from further analysis. To detect the differentially 
expressed genes between treatment and control, a 
nonparametric bootstrap method (42) was used to 
compute the raw p-value for each gene.  The eight 
chips from both the treatment groups and the 
control groups were re-sampled for 9,999 times 
with nonparametric bootstrapping, and t statistics 
of each gene was calculated for each re-sampling,.  
The raw p value for each gene was obtained by 
ranking the original t statistics value in the 9,999 
re-sampling t statistics values.  The differentially 
expressed genes were then determined by 
controlling the false-discovery rate (FDR) at the 
1% level (43).  From the total data pool, 48 genes 
relevant to IGF-1 signaling were found to be 
significantly impacted and reported in this study.  
Gene expression confirmation by RT-PCR: RT-
PCR reaction was carried out by using purified 
total RNA obtained as described above. The 
cDNA was synthesized by RT-PCR using one-step 
RT-PCR kit (Qiagen, Valeacia, CA). The primers 
are derived from published gene sequences as 
follows: MAPK1: sense primer 5'-TCT CCC GCA 
CAA AAA TAA GG-3', antisense primer 5'-TCG 
TCC AAC TCC ATG TCA AA-3'; H-ras: sense 
primer 5’-TGT TAC CAA CTG GGA CGA CA-
3’, antisense primer 5’-TCT CAG CTG TGG TGG 
TGA AG-3’; PI3Kca: sense primer 5'-TGT TTG 
CAA AGA AGC TGT GG-3', antisense primer 5'-
TAT GAC CCA GAG GGA TTT CG-3'; IGFBP3: 
sense primer 5’-AAG TTC CAT CCA CTC CAT 
GC-3’, antisense primer 5’-AGC TCT GCT TTC 
TGC CTT TG-3’; lepr: sense primer 5'-AGG CCC 
AGA CAT TTT TCC TT-3', antisense primer 5'-
TCC TGG AGG ATC CTG ATG TC-3'; β-actin: 
sense primer 5’-TGT TAC CAA CTG GGA CGA 
CA-3’, antisense primer 5’-TCT CAG CTG TGG 
TGG TGA AG-3’. Fifty μL of PCR reaction were 
run with a final concentration of 200 μM of dNTP 
mix, 1 x PCR buffer, 1 μM of each primer, and 1.0 
U of Taq polymerase. Thermal cycling conditions, 
following an initial denaturation at 94 °C for 4 
min, were as follows: 30 sec at 95 °C, annealing at 
55 °C for 30 sec, and extension at 72 °C for 1 min. 
Then samples were incubated at 72 °C for 7 min. 
Amplified products at 8 μL were loaded and 
separated on a 1.5% agarose gel. The RT -PCR 
products were visualized under UV light by the 
FluorChemTM 8800 Advanced Imaging System 
(Alpha Innotech, San Leandro, CA). The relative 
density of the target band was normalized to the 
loading control β-actin and then expressed as a 
percentage of the controls. 
Statistic analysis: The overall effects of 
treatments on body weight, body fat, and IGF-1 
levels were analyzed by one-way ANOVA, and 
then the least significant difference method 
(Fisher’s LSD) was used to compare each of the 
treatment groups and the control group. Each set 
of comparisons for a given variable will be 
conducted at the overall 0.05 level of significance 
by applying Dunnett’s adjustment. In the 
experiments of RT-PCR, activated Ras-GTP, 
western blotting, and immunohistochemistry, a 
complete randomized block design was used with 
each running gel as a block effect and analyzed by 
ANOVA and contrast analysis. All the statistical 
processes were carried out with SAS software. 
 
RESULTS 
Impact of DCR and exercise on Body weight 
and body fat: Figure 1A shows the effects of 20% 
DCR and exercise with or without diet intake 
limitation on body weight. Adult SENCAR mice 
in the control group gradually gained weight 
throughout the experimental period (P < 0.01, 
body weight at wk 12 vs. wk 1); however, mice at 
20% DCR or 20% DCR plus exercise consistently 
lost weight during the experimental period (P < 
0.01, body weight at wk 12 vs. wk 1). The PF+Exe 
mice had significantly lowered body weight at the 
end of the experiment when compared with the 
controls or AL+Exe group. By the end of the 
experiment, the mean weights of PF+Exe, DCR 
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and DCR+Exe mice were significantly lower than 
the controls. The weight of AL+Exe group was not 
significantly lower when compared with the 
sedentary counterparts, which might be, at least in 
part, due to their increased food intake (4.0 ± 0.2 
g/day for control mice vs. 4.3 ± 0.4 g/day for 
AL+Exe mice). Consequently, percent body fat, as 
shown in Figure 1B, significantly decreased in 
PF+Exe, DCR, and DCR+Exe groups, but not 
AL+Exe group, when compared with the controls. 
No significant change of bone mineral density was 
found among groups (data not shown). 
Impact on plasma IGF-1 and skin tissue IGF-
1R levels: As shown in Figure 2A, plasma IGF-1 
levels were significantly reduced in DCR and 
DCR+Exe groups when compared with control 
counterparts. Statistical analysis of the exercise 
factor with three exercise groups (AL+Exe, 
PF+Exe, and DCR+Exe) combined together 
demonstrated a significant decrease of IGF-1 
levels in exercise-treated mice, but individual 
group alone did not show any significant change 
between exercise and control (data not shown). 
The protein levels of IGF-1R in skin tissues were 
not significantly different among groups (Figure 
2B). 
Impact on Ras-MAPK pathway: The protein 
levels of H-Ras, but not K-Ras, were significantly 
reduced in DCR and DCR+Exe mice. However, 
exercise did not show a significant effect (Figure 
3A). The activated Ras-GTP, as measured by a 
pull down assay, was also significantly reduced in 
DCR and DCR+Exe mice, but not in exercise with 
ad libitum or pair-feeding mice in comparison 
with the control counterparts (Figure 3B). RT-
PCR analysis indicated no significant alteration of 
H-ras gene expression among groups (Figure 3C). 
The p42/p44-MAPK levels were reduced 
significantly in DCR, DCR+Exe, and PF+Exe 
groups in comparison with the controls (Figure 
3D). 
Impact on PI3K-Akt pathway: The protein 
levels of PI3K significantly decreased in DCR, 
DCR+Exe, and PF+Exe mice when compared with 
the controls (Figure 4A). While the levels of Akt 
protein did not change, the levels of phosphor-
serine Akt were significantly lower in DCR, 
DCR+Exe, and PF+Exe groups (Figure 4B). 
Impact on local protein expression in skin 
tissues: Expression of PI3K, H-Ras, PCNA, leptin, 
and caspase-3 proteins in epidermis, dermis, 
follicles, and subcutaneous fat of the skin tissues 
was respectively assessed by 
immunohistochemistry. Representative images of 
PI3K, PCNA, and caspase-3 staining in epidermis 
and H-Ras staining in subcutaneous fat from 
acetone- or TPA-treated skin tissues were shown 
in Figure 5. In comparison with the acetone-
treated control, TPA treatment significantly 
increased staining densities of PI3K, PCNA, and 
caspase-3 in epidermis as well as H-Ras in 
subcutaneous fat, respectively. However, TPA-
enhanced densities of PI3K and PCNA in 
epidermis as well as H-Ras in subcutaneous fat 
significantly decreased in DCR and PF+Exe 
groups. There were no significant differences in 
AL+Exe group when compared with TPA-treated 
positive control only. There were no statistical 
differences of leptin (figure 6) and caspase-3 
staining between treatment groups. 
Effect on plasma leptin levels: In contrast to an 
unchanged local leptin production in the skin 
subcutaneous fat cells, plasma leptin levels in 
PF+Exe, DCR, and DCR+Exe groups but not 
AL+Exe group were significantly reduced in 
comparison with ad libitum-fed controls (Figure 
6). 
Effect on activated caspase-3 levels in skin 
tissues: Although the expression of caspase-3 
protein in local skin cells as measured by 
immunohistochemistry was not changed, the 
caspase-3-like proteolytic activity in the cell 
lysates of skin tissues was potentially but 
insignificantly elevated following exercise- and/or 
DCR-treatments. A significant increase was found 
in DCR+Exe mice only when compared with that 
in the controls (Figure 7). 
Effects of gene expression relevant to Ras and 
PI3K signaling pathways: By using Affymetrix 
microarray, we detected the effects of treatments 
on the expression of 39,000 transcripts with 
45,101 probe sets in the skin tissues 2 hrs after 
TPA application. As shown in Table 1, 34 marker 
genes relevant to PI3K and 31 genes related to 
Ras-MAPK pathway were significantly changed. 
Eight of the marker genes relevant to PI3K and 
eleven genes to MAPK significantly decreased in 
DCR-fed mice, while five genes to PI3K and three 
to MAPK were considerably lowered in pair-fed 
but exercised mice. DCR-treatment also up-
regulated expression of 15 genes related to PI3K 
and 14 genes to MAPK. In exercised mice with 
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pair feeding, 8 genes relevant to PI3K and 7 to 
MAPK significantly over-expressed when 
compared with the sedentary controls. 
RT-PCR confirmation: The microarray data 
were further validated by using RT-PCR for five 
randomly selected genes in IGF-1-related 
categories. As shown in Figure 8 (MAPK1, 
PI3Kca, IGFBP3, and lepr) and Figure 3C (H-ras), 
the gene expression of MAPK1, PI3Kca, IGFBP3, 
and lepr was significantly decreased in DCR and 
DCR+Exe groups in comparison with the control 
group. PI3Kca expression was also reduced in 
PF+Exe group. The expression of H-ras was not 
significantly changed between experimental 
groups. The RT-PCR confirmation rate to the 
microrray data set, as estimated by using a 
Bayesian statistical method, is about 93.3%. 
Impact on PI3K by IGF-1 treatment: The mice 
in PF+Exe group were received i.p. injection with 
either saline (sham) or IGF-1 at 10 μg/g B.W. 
twice per wk in the last two weeks. As shown in 
Figure 9, the levels of  expression in skin samples 
were significantly reduced in PF+Exe when 
compared to the controls. However, the reduced 
PI3K in PF+Exe group was partially reversed by 
IGF-1 injection. 
DISCUSSION 
The major foci of this study are to 
elucidate the potential mechanisms of cancer 
prevention by weight loss and to compare the 
impact between DCR and physical activity. By 
using a combined weight control protocol with 
DCR and exercise components in an epidermal 
carcinogenesis-sensitive mouse strain, we assessed 
the effects of DCR and exercise on body weight, 
body fat, and plasma IGF-1 levels. The 
mechanistic impact of body weight reduction by 
DCR or exercise on Ras-MAPK and PI3K-Akt 
signal pathways was further assessed in cancer 
promoter phorbol ester-promoted skin tissues.  
Previous data have shown DCR at 10% 
does not affect DMBA-induced tumor incidence in 
rats, but reduces tumor size (44). At 20% DCR, 
tumor incidence fell by one third, and tumor size 
was reduced similar to that of 10% DCR (44). The 
30% and 40% DCR reduced both tumor incidence 
and size even more (45). However, certain 
undesired side effects occurred at the level greater 
than 30% DCR (46). In this study, we chose 20% 
DCR and introduced treadmill exercise for the first 
time to compare the impact of weight control 
between decreasing calorie intake and increasing 
energy expenditure. 
As expected, we found that body weight 
significantly decreased with 20% DCR, which 
corresponded to a decrease of body fat and plasma 
IGF-1 levels. In contrast to DCR treatment, the 
impact of treadmill exercise demonstrated a 
modest but intricate result for weight maintenance. 
Exercise alone with ad libitum feeding was not 
sufficient to decrease body weight due to, at least 
in part, the corresponding increase in dietary 
intake. However, the dietary energy increase in 
AL+Exe might not necessarily match the treadmill 
exercise-induced energy expenditure, since the 
energy expenditure could have been altered due to 
the changed spontaneous activity in the cage 
and/or resting energy metabolism, etc. If the food 
intake of the exercised mice was limited by pair-
feeding with sedentary counterpart, then body 
weight and body fat were significantly reduced. 
Plasma levels of IGF-1 seemed lowered, but were 
not significantly reduced by exercise. It should be 
noted that the caloric deficit was not matched 
between the exercise and DCR interventions, and 
thus the results should be interpreted accordingly. 
The estimated increase in energy expenditure by 
treadmill exercise at a moderate intensity in this 
study (13.4 m/min for 60 min/d, 5 d/wk for 10 
wks) seems much lower than the 20% reduction in 
dietary calorie intake. Particularly, the lack of an 
exercise effect in AL+Exe mice on the body 
weight/fat, IGF-1, and various signaling markers 
might be in part due to the insufficient energy 
expenditure of exercise. In comparison with DCR, 
therefore, a partial inhibition of signaling 
pathways by PF+Exe and no inhibition by 
AL+Exe may be more attributable to the 
magnitude of the calorie deficit than the dietary 
calorie intake vs. exercise comparison.  
Although negative energy balance is a 
fundamental cause of weight loss, the body weight 
in the DCR group combined with exercise 
treatment did not show any additive decrease 
when compared with DCR alone. Clearly, the role 
of physical activity in total energy expenditure and 
energy homeostasis is complicated. Badman and 
Flier recently summarized that the total energy 
expenditure should consist of physical activity, 
adaptive thermogenesis, and obligatory energy 
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expenditure (46). It should be noted that both 
calorie restriction and exercise have been found to 
suppress plasma thyroid hormones (47-48). It is 
well known that thyroid hormones enhance energy 
conservation and resist loss of weight. It is 
possible that the combination of calorie restriction 
and exercise could suppress thyroid hormone 
action to a greater extent than calorie restriction 
alone and therefore explain the similar weight loss 
for both types of treatments. 
The signaling transduction pathways 
promoted by TPA in skin carcinogenesis are well 
characterized. Briefly, TPA activates PKC-Raf-
MAPK signal transduction pathways and then 
promotes proliferation. Previous studies have 
demonstrated that DCR inhibited skin 
carcinogenesis by suppressing TPA-induced AP-1 
transcriptional activation via blocking PKC-Raf-
ERK signal (32-34). Our current data provide 
significant novel information that the reduction of 
circulating IGF-1 levels may induce an abrogated 
IGF-1-dependent signaling, and thereby co-inhibit 
TPA-induced cancer promotion.  
While the basal levels of most signaling 
events tested in acetone-treated TPA-free skin 
tissues were not significantly impacted by DCR 
intervention (33-34), we found that 20% DCR for 
10 wks significantly inhibited TPA-promoted Ras-
MAPK and PI3K-Akt pathways as well as 
proliferative marker PCNA. The finding that H-
Ras protein levels and activated Ras levels are 
depressed by DCR is in agreement with the skin 
tissue specificity of Ras. It is interesting that 
immunohistochemistry staining indicates that the 
decrease of H-Ras expression occurred in 
subcutaneous fat cells, but not in epidermis. To 
our knowledge, this is the first study to report that 
DCR reduces TPA-induced H-Ras expression in 
subcutaneous fat cells. It is not clear how a 
reduction of H-Ras in subcutaneous fat may 
impact skin carcinogenesis that originally 
develops from epidermis. The role of 
subcutaneous fat on malignant melanoma, 
however, has been suggested via tumor-stroma 
interaction required during metastases (49) or 
early micrometastases (50). Recent data also 
suggest that adipocytes not only respond to 
hormonal signals, but also produce hormone-like 
factors such as adiponectin or pro-inflammatory 
adipocytokines that may enhance oncological risk 
(51-52). Therefore, we further measured the local 
production of leptin in skin subcutaneous fat cells 
and found that was not significantly changed by 
either diet or exercise treatment. It is interesting 
that a significant decrease of plasma leptin levels 
was found in PF+Exe, DCR, and DCR+Exe 
groups, suggesting other resources of circulating 
leptin such as abdominal fat. The earlier study by 
Michna et al. (11) showed 31-42% lower weight 
of parametrial fat pads in the wheel running mice 
when compared to non-runners. Although the 
runners did not significantly lose body weight due 
to increased food intake, they had a significant 
inhibition against UVB-induced skin 
carcinogenesis (11). Therefore, a dietary 
consideration by pair-feeding in the exercised 
mice might be not necessary for cancer prevention. 
The lack of altered skin signaling events in 
AL+Exe group in this study might be related to 
absence of body fat loss, which is consistent with 
the results in the PF+Exe group. Follow-up studies 
in the Wang laboratory are on-going to look for 
the association of reduced body fat with plasma 
leptin levels as well as lipidomics profiling in 
exercised mice. 
In contrast to DCR that suppressed both 
Ras-MAPK and PI3K-Akt pathways in TPA-
treated skin tissues, treadmill exercise with pair-
feeding selectively reduced only the PI3K-Akt 
pathway. The activation of the PI3K-Akt pathway, 
as marked by p110 PI3K protein levels, activated 
phosphor Akt, p110 PI3K protein expression in 
epidermis, and their corresponding gene 
expression, was significantly lower in DCR, 
DCR+Exe, and PF+Exe groups in comparison 
with the controls. The selective inhibition of PI3K-
Akt signaling in phorbol ester-promoted skin 
samples by exercise with pair-feeding may be 
associated with anti-apoptosis. Depressing this 
signaling pathway may increase apoptosis and thus 
protect against cancer development (53-54). We 
further measured the levels of caspase-3 as an 
apoptosis marker and found that the caspase-3-like 
proteolytic activity did potentially increase but not 
significant following physical activity or DCR 
treatments. A significant increase in caspase-3 
activity by the combination of DCR and exercise 
together may further support an involvement of an 
apoptosis-mediated mechanism.  
It is well known that not only IGF-1 but 
also some other hormones or growth factors such 
as insulin and leptin could activate both PI3K-Akt 
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and Ras-MAPK signal cascades. It is interesting 
that IGF-1 injection partially abolished the 
suppression of PI3K in pair-fed and exercised 
mice, suggesting a requirement of IGF-1 reduction 
on down-expression of p110 PI3K protein 
observed in those mice. We still cannot exclude 
the involvement of other hormones that have been 
found to be significantly changed in response to 
weight control (13, 14-17). Future studies to 
elucidate the individual or the combined effects of 
IGF-1 with other changed hormones on PI3K and 
Ras signaling in weight controlled mice appear to 
be warranted. 
By using our established strategies to 
control body weight, we measured the genomic 
gene expression in TPA-promoted skin tissues and 
compared the TPA-induced gene expression 
profiles between exercise and DCR treatments. Of 
the 39,000 transcripts with 45,101 probe sets 
measured, we identified 559 genes that showed at 
least 1.5-fold significant change by DCR and/or 
exercise treatments in comparison with the 
controls. Of these 559 genes, 411 genes were 
altered by DCR, 110 genes were changed by 
AL+Exe, and 67 genes were changed by PF+Exe. 
By using gene ontology annotation, we identified 
the altered genes in 21 major biological processes 
including cell growth, cell maintenance, cell 
communication, DNA binding, transcription 
factor, and transcription activity categories. A list 
of all the genes that significantly changed by either 
DCR or exercise treatment with all the gene 
ontology categories has been published separately 
(55). The results of 34 genes relevant to PI3K 
pathway and 31 genes related to MAPK pathway 
were selected to report here. Much of the altered 
genes were consistent with the results of protein 
and active protein measurements, which showed 
the treatments of DCR and exercise with pair-
feeding suppressed the expression of 16 genes 
relevant to PI3K or MAPK pathways. However, 
some of the marker genes were unexpectedly over-
expressed. The precise reason underlying this 
discrepancy is unknown. Considering that the 
microarray data were detected at one time point, a 
time course of gene expression in response to TPA 
treatments and the corresponding proteomic data 
may help to explain any potential inconsistencies. 
An alternative explanation for the unexpected gene 
over-expression observed from microarray results 
may be associated with potential crosstalk by other 
undetected pathways. This could also explain the 
data by which exercise with pair feeding did not 
affect Ras protein and activity levels, but 
attenuated downstream MAPK activity and then 
TPA-induced PCNA staining.  
Taken together as illustrated in Figure 10, 
the well-known cancer prevention by DCR 
treatment, therefore, appears to be a consequence 
of the reduced Ras/MAPK in subcutaneous fat and 
PI3K/Akt signaling in epidermis, and results in 
decreased sensitivity to TPA stimuli in skin tissues 
leading to suppressed proliferation and expressed 
potential apoptosis. Exercise with limited dietary 
intake, but not exercise alone, induced a decrease 
of PI3K/Akt signaling in epidermis. These 
reductions seem to be related to the decrease of 
circulating IGF-1 levels, but an involvement of 
other hormones such as insulin and leptin might 
not be excluded. 
In conclusion, this study demonstrated for 
the first time that a successful strategy to control 
body weight via decreasing calorie intake or 
increasing physical activity led to the reduction of 
corresponded Ras-MAPK and/or PI3K-Akt 
pathways. DCR induced substantial weight loss 
and significantly decreased IGF-1 levels for a 
comprehensive inhibition of both MAPK and 
PI3K pathways. DCR alone was as effective as 
DCR+Exe, indicating that DCR, independent of 
exercise, is a potent inhibitor for tumor-promoting 
pathways. Exercise with pair-feeding but not 
exercise alone, however, only selectively 
restrained the PI3K pathway, which seemed more 
attributable to the magnitude of the caloric deficit 
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Table 1: Impact of weight control via dietary calorie restriction (DCR) or treadmill exercise with 
pare feeding (PF+Exe) on the expression of 48 genes up regulated (↑) or down regulated (↓) that are 
relevant to MAPK (+) and/or PI3K (+) pathways. 
Accession Number Symbol PI3K  MAPK  DCR PF+Exe 
BB248138 Dmtf1 + + ↓  
BG143376 Prkcz + + ↓  
AI451506 Rps6kb1 + + ↓ ↓ 
BB389420 Prkca + + ↓  
BB141769 Braf  + ↓  
AW553456 Map2k2  + ↓  
AV377656 Map3k5  + ↓  
BG070504 Map4k4  + ↓  
NM_011949 Mapk1  + ↓  
BI414398 Mapk3  + ↓  
BB018528 Nras  + ↓ ↓ 
NM_008113 Arhgdig +  ↓ ↓ 
AI528567 Pik3ca +  ↓ ↓ 
NM_008841 Pik3r2 +  ↓  
BM207149 Rps6kc1 +  ↓ ↓ 
AI649005 Igfbp3 + + ↑  
BB345784 Irs1 + + ↑  
BM124366 Lepr + + ↑  
NM_008860 Prkcz + + ↑  
BB370469 Map3k12  + ↑  
BE948629 Map3k3  + ↑ ↑ 
BQ174980 Mapkbp1  + ↑  
AI987929 Ndrg1  + ↑  
NM_008681 Ndrl  + ↑ ↑ 
BB354696 Rasgrp1  + ↑  
BF019839 Akt1s1 +  ↑  
BM222798 Arhgap15 +  ↑  
BB749468 Arhgap17 +  ↑  
NM_133962 Arhgef18 +  ↑  
NM_017367 Ccni +  ↑  
BI872151 Ccnt2 +  ↑  
NM_010585 Itpr1 +  ↑  
NM_008713 Nos3 +  ↑ ↑ 
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BC017537 Pik3r4 +  ↑  
BG069493 Rgnef +  ↑ ↑ 
BG972377 Tnfrsf21 +  ↑  
NM_031880 Tnk1 +  ↑ ↑ 
NM_010517 Igfbp4 + +  ↓ 
BM201230 Map3k9  +  ↑ 
BB469472 Mapkapk3  +  ↑ 
NM_025846 Rras2  +  ↑ 
AI324972 Sp4  +  ↑ 
AI746342 Stat6  +  ↑ 
BF018155 Pik3cb +   ↑ 
BG076163 Crebbp +   ↑ 
NM_019923 Itpr2 +   ↑ 
BB752796 LOC547217 +   ↑ 




Figure 1. Effect of DCR and exercise on body weight and percent body fat. Female SENCAR mice at 
9 wks of age (27.6 ± 2.8 g) were divided into five groups: ad libitum sedentary (Control), ad libitum 
exercise (AL+Exe), Pair-fed plus exercise (PF+Exe), 20% DCR (DCR), and 20% DCR plus exercise 
(DCR+Exe). ). The mice were fed either a basal diet (AIN-93) or a 20% DCR diet for 12 wks. The 
PF+Exe group was paired-fed at the same amount as the ad libitum sedentary group. Mice performed 
treadmill exercise at 13.4 m/min for 60 min/d, 5 d/wk for 10 wks. A: Body weights of the mice at the 
final week were significantly reduced in DCR, DCR+Exe, and PF+Exe groups. Results are means of n = 
8-12 per group. Means with different letters differ significantly (P ≤ 0.05). B: Body composition of the 
mice at the final week was measured by DXA scan. Percent body fat significantly decreased in DCR, 
DCR+Exe, and PF+Exe groups. Results are mean ± SE (n = 8-12, *P ≤ 0.05 vs. the controls). 
Figure 2. Effect of DCR and exercise on plasma IGF-1 and skin tissue IGF-1R levels. Total IGF-1 
levels in plasma were measured by a RIA kit. A: The plasma IGF-1 levels in DCR and DCR+Exe groups 
were significantly reduced in comparison with ad libitum-fed controls.  B: The protein levels of IGF-1R 
in skin tissues as measured by western blotting were not significantly changed between groups. The 
relative expression level of IGF-1R was normalized to the level of loading control β-actin and then 
expressed as a ratio to the controls. Results are mean ± SE (n = 8-12, *P ≤ 0.05 vs. the controls). 
Figure 3. Effect of DCR and exercise on IGF-1-dependent Ras-MAPK Pathway. A: Levels of H-Ras 
(white bar), but not K-Ras(black bar), significantly reduced in DCR and DCR+Exe groups. B: Activated 
Ras measured by pull down assay as described under “Experimental Procedure” significantly decreased in 
DCR and DCR+Exe groups when compared to the controls. C: H-ras gene expression measured by RT-
PCR as described under “Experimental Procedures” was not significantly altered between groups. D: 
Levels of p42/p44-MAPK in PF+Exe, DCR, and DCR+Exe groups were significantly reduced when 
compared to the controls. The densities of the appropriate band were quantified by the FluorChemTM 8800 
Advanced Imaging System. The relative density of the target band was normalized to the loading control 
β-actin and then expressed as a ratio to the controls. Results are presented as mean±SE (n = 7, *P ≤ 0.05 
vs. the controls). 
Figure 4. Effect of  DCR and exercise on IGF-1-dependent PI3K-Akt Pathway: A: Levels of p110 
PI3K protein were significantly reduced in PF+Exe, DCR, and DCR+Exe groups. B: p-Akt(Ser473), but 
not Akt, significantly decreased in PF+Exe, DCR, and DCR+Exe groups when compared to the controls. 
The expression levels of the proteins were quantified by the FluorChemTM 8800 Advanced Imaging 
System. The relative density of the target band was normalized to the loading control β-actin and then 
expressed as a ratio to the controls. Results are presented as mean±SE (n = 7, *P ≤ 0.05 vs. the controls). 
Figure 5. Detection of protein expression of PI3K, H-Ras, PCNA, and caspase-3 by 
immunohistochemistry staining. Representative histological skin sections with immunohistochemical 
staining as described under “Experimental Procedures” for PI3K, PCNA, and caspase-3 in epidermis and 
H-Ras in subcutaneous fat in acetone-treated control (A) and those TPA-treated mice from control (B), 
DCR (C), PF+Exe (D), and AL+Exe (E) are shown. The arrows indicate representative staining of a target 
protein in epidermis and subcutaneous fat cells, respectively. TPA significantly enhanced the densities of 
PI3K, PCNA, and caspase-3 in epidermis as well as H-Ras in subcutaneous fat cells compared with 
acetone-treated controls. The TPA-induced densities of PI3K, PCNA, and H-Ras but not caspase-3 
staining significantly decreased in DCR and PF+Exe groups when compared with the TPA-treated 
controls (P ≤ 0.05, n=3-5). 
Figure 6. Effect of DCR and exercise on plasma leptin and local leptin production in skin 
subcutaneous fat. Plasma leptin levels as measured by a RIA kit in DCR and DCR+Exe groups were 
significantly reduced in comparison with ad libitum-fed controls.  The production of local leptin in 
subcutaneous fat cells as measured by immunohistochemistry staining was not significantly changed 
between treatment groups. Results are mean ± SE (n = 6-9, *P ≤ 0.05 vs. the controls). 
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Figure 7: Effect of DCR and exercise on proteolytic activity of caspase-3. The cell lysates of skin 
tissues taken 2 hrs after TPA application were incubated with fluorogenic caspase-3 substrate as described 
under “Experimental Procedures”. A significant increase in caspase-3-like proteolytic activity in 
DCR+Exe mice was found when compared with the controls (n=3-4, *P ≤ 0.05 vs. the controls). 
Figure 8: Confirmation of microarray data by RT-PCR. Five genes were randomly chosen from 
cancer-related categories and their expression pattern in comparison with the microarray data was 
validated by RT-PCR as showed in Figure 8 and Figure 3c, respectively. Identical results were obtained 
with MAPK1, PI3Kca, IGFBP3, and lepr genes but nor H-ras gene that down-expressed significantly in 
DCR and DCR+Exe groups. The gene expression of PI3K was also significantly reduced in PF+Exe 
group. 
Figure 9. Impact on p110-PI3K protein levels by IGF-1 treatment: As mentioned above in Figure 1, 
the PF+Exe mice were paired-fed at the same amount as the ad libitum sedentary group and performed 
treadmill exercise at 13.4 m/min for 60 min/d, 5 d/wk for 10 wks. In the last two weeks, they were i.p. 
injected with saline (sham) or IGF-1 at 10 μg/g B.W. twice per wk. Levels of p110-PI3K protein as 
measured by Western blotting were significantly reduced in PF+Exe when compared to the controls. 
However, the reduced PI3K in PF+Exe group was partially reversed by IGF-1 injection. Results are mean 
± SE (n = 5-7). Bars with different alphabetical letters differ significantly, P ≤ 0.05. 
Figure 10. Hypothesized weight control-induced inhibitory crosstalk between IGF-1-dependent and 
TPA-promoted signaling pathways. Dietary calorie restriction reduced circulated IGF-1 levels and then 
suppressed TPA-activated Ras-MAPK and PI3K-Akt pathways in both protein and gene expression 
levels. Exercise with pair-feeding reduced the PI3K-Akt pathway and MAPK-p42/44, but exercise with 
ad libitum feeding did not affect body weight, plasma IGF-1, or any of the signaling pathways that were 
studied. 
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